- Report
- February 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- March 2019
- 44 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- March 2022
- 172 Pages
Global
From €5963EUR$6,168USD£5,122GBP
- Book
- May 2023
- 272 Pages
- Book
- February 2010
- 260 Pages
Bradycardia is a condition in which the heart rate is slower than normal. It is a common type of arrhythmia, or irregular heartbeat, and can be caused by a variety of factors, including aging, certain medications, and underlying medical conditions. In cardiology, bradycardia is typically treated with pacemakers, which are small devices that are implanted in the chest to help regulate the heart rate. Pacemakers can be used to treat both symptomatic and asymptomatic bradycardia, and can be programmed to adjust the heart rate as needed.
In addition to pacemakers, other treatments for bradycardia include medications, lifestyle changes, and surgery. Medications can be used to help regulate the heart rate, while lifestyle changes such as exercise and stress management can help reduce the risk of developing bradycardia. Surgery may be necessary in some cases, such as when the cause of the bradycardia is a structural abnormality in the heart.
The bradycardia market is a growing segment of the cardiology industry, with a variety of companies offering products and services related to the diagnosis and treatment of bradycardia. Some of the major players in the market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and Sorin Group. Show Less Read more